2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Wilms Tumor
Wilms tumor, a rare kidney cancer primarily affecting children, presents a unique challenge in cancer research. Researchers are exploring various aspects to understand its etiology and improve treatment outcomes. Genomic studies have identified mutations in genes like WT1 and CTNNB1, shedding light on the tumor's genetic basis. Advances in imaging technologies aid in early detection, crucial for successful treatment. Additionally, targeted therapies, such as those inhibiting angiogenesis or exploiting specific molecular pathways, offer promising avenues. Immunotherapy, harnessing the body's immune system to fight cancer cells, is also being investigated. Collaborative efforts between oncologists, geneticists, and immunologists are crucial in unraveling Wilms tumor's complexities and devising effective therapeutic strategies. Through interdisciplinary research, the aim is to enhance survival rates and quality of life for children battling this challenging malignancy.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China